Clinical Trials · NCT07825857
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 228
- Start date
- Oct 2026
- Locations
- 4 sites, United States
- Primary endpoint
- Treatment response